IHS Chemical Week

Regions :: Western Europe :: Switzerland

Carbogen Amcis invests in ADC capabilities

12:09 AM MDT | October 3, 2013 | Deepti Ramesh

Carbogen Amcis (Bubendorf, Switzerland), a pharma process-development and active pharmaceutical ingredient (API) manufacturing subsidiary of Dishman Pharmaceuticals and Chemicals (Ahmedabad, India) says it is investing to enhance its antibody drug conjugate (ADC) capabilities in order to better respond to increasing demand for ADCs in the development of highly targeted cancer treatments. The investments include a $4-million clean room clinical supply facility at the Bubendorf site and nearly a $1-million upgrade of the sterile manufacturing area in the facility...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa